# 바이오스페이스 일일 뉴스 리포트 - 2025년 07월 21일


## 주요 헤드라인

1. **BMS’ Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/bms-anemia-drug-reblozyl-flunks-phase-iii-myelofibrosis-trial>

2. **BMS’ Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/bms-anemia-drug-reblozyl-flunks-phase-iii-myelofibrosis-trial>

3. **GSK’s Blenrep Loses Adcomm Vote, Further Clouding Comeback Bid (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/gsks-blenrep-loses-adcomm-vote-further-clouding-comeback-bid>

4. **Sarepta Reports a Third Gene-Therapy Related Patient Death (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/sarepta-reports-a-third-gene-therapy-related-patient-death>

5. **Sarepta Up 18% After Business Overhaul as Analysts Cautiously Optimistic (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sarepta-up-18-after-business-overhaul-as-analysts-cautiously-optimistic>

6. **Patients Fight for Access to BrainStorm’s ALS Drug After Expanded Access Data ‘Defy Logic’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/patients-fight-for-access-to-brainstorms-als-drug-after-expanded-access-data-defy-logic>

7. **Patients Fight for Access to BrainStorm’s ALS Drug After Expanded Access Data ‘Defy Logic’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/patients-fight-for-access-to-brainstorms-als-drug-after-expanded-access-data-defy-logic>


---
*2025년 07월 21일 바이오스페이스 뉴스 피드에서 생성된 리포트*